ClinicalTrials.Veeva

Menu

PRactice of Ventilation and Adjunctive Therapies in COVID-19 Patients. (PRoVAcT-COVID)

A

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Status

Completed

Conditions

COVID-19 Acute Respiratory Distress Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT05954351
PRoVAcT-COVID

Details and patient eligibility

About

PRactice of Ventilation and Adjunctive Therapies in COVID-19 Patients. An observational study of ventilation practice and adjunctive therapies in critically ill, invasively ventilated COVID-19 patients during the first and second surge of COVID-19 in the Netherlands.

Enrollment

2,465 patients

Sex

All

Ages

18 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • receiving invasive ventilation or high-flow nasal oxygen for COVID-19 for SARS-CoV-2
  • admitted to one of the ICUs of the participating hospitals

Exclusion criteria

  • none

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems